Citrate Anticoagulation for CRRT in Children: Comparison with Heparin

Table 2

Clinical characteristics of children treated with heparin and citrate.

	Citrate	Heparin	𝑃
	Median (IQR)	Median (IQR)
Age (months)	36.0 (5.6–103.7)	33.0 (5.6–84.0)	0.882
Weight	13.4 (6.8–28.8)	9.8 (6.3–19.8)	0.585
PRISM (% of mortality)	12.6 (3.4–20.8)	10.0 (6.4–31.4)	0.716
PIM (% of mortality)	16.6 (6.9–22.6)	10.6 (5.5–20.4)	0.431
MOF	3 (3–3.75)	3 (3-4)	0.681
PELOD (% of mortality)	11 (11–21)	21 (12.25–22)	0.145
Lactic acid	2.5 (1.3–6.8)	1.4 (1.0–2.4)	0.075
Inotropic score	40 (18–54)	38 (4–53)	0.540
Mechanical ventilation	91.7%	81.8%	0.635
Mortality	25%	25%	1.000

IQR: interquartile range. MOF: multiorgan failure.